Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4

Nature Communications

Volumn 5, Issue , 2014, Pages

  Catanzaro, Joseph M ^a   Sheshadri, Namratha ^a   Pan, Ji An ^a   Sun, Yu ^a   Shi, Chanjuan ^b   Li, Jinyu ^c   Powers, R Scott ^c   Crawford, Howard C ^d   Zong, Wei Xing ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 1; SQUAMOUS CELL CARCINOMA ANTIGEN 2; TRANSCRIPTION FACTOR PEA3; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; PROTEIN P21; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ANTIGEN; CANCER; GENE EXPRESSION; INHIBITOR; MUTATION; PROTEIN; PUBLIC HEALTH; TUMOR;

ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE RAS; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR XENOGRAFT; UNFOLDED PROTEIN RESPONSE; UPREGULATION; BIOSYNTHESIS; METABOLISM; PHYSIOLOGY;

ANTIGENS, NEOPLASM; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; PROTO-ONCOGENE PROTEINS P21(RAS); SERPINS; UP-REGULATION;

EID: 84899478638     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4729     Document Type: Article

References (53)

1. Bos, J. L. Ras oncogenes in human cancer: A review. Cancer Res. 49, 4682-4689 (1989
2. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22 (2003
3. Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447-458 (2004
4. Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G. & Bar-Sagi, D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836-847 (2012
5. Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukindependent inflammatory network. Cell 133, 1019-1031 (2008
6. Coppe, J. P. et al. Senescence-associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868 (2008
7. Ancrile, B., Lim, K. H. & Counter, C. M. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 21, 1714-1719 (2007
8. Leslie, K. et al. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Res. 12, R80 (2010
9. Schneider, S. S. et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl Acad. Sci. USA 92, 3147-3151 (1995
10. Catanzaro, J. M. et al. Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma. PLoS ONE 6, e19096 (2011
11. Guido, M. et al. Squamous cell carcinoma antigen in human liver carcinogenesis. J. Clin. Pathol. 61, 445-447 (2008
12. Vassilakopoulos, T. et al. Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 32, 137-144 (2001
13. Cataltepe, S. et al. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J. Histochem. Cytochem. 48, 113-122 (2000
14. McGettrick, A. F., Barnes, R. C. & Worrall, D. M. SCCA2 inhibits TNF-mediated apoptosis in transfected HeLa cells. The reactive centre loop sequence is essential for this function and TNF-induced cathepsin G is a candidate target. Eur. J. Biochem. 268, 5868-5875 (2001
15. Suminami, Y. et al. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br. J. Cancer 82, 981-989 (2000
16. Brioschi, P. A., Bischof, P., Delafosse, C. & Krauer, F. Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma. Int. J. Cancer 47, 376-379 (1991
17. Scambia, G. et al. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy. Am. J. Obstet. Gynecol. 164, 631-636 (1991
18. Ngan, H. Y., Chan, S. Y., Wong, L. C., Choy, D. T. & Ma, H. K. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix. Gynecol. Oncol. 37, 260-263 (1990
19. Suminami, Y. et al. Promoter analyses of SCC antigen genes. Biochim. Biophys. Acta 1727, 208-212 (2005
20. Young, A. R. et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798-803 (2009
21. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997
22. Kikuchi, H., Pino, M. S., Zeng, M., Shirasawa, S. & Chung, D. C. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and-2alpha in colon cancer. Cancer Res. 69, 8499-8506 (2009
23. Baines, A. T., Xu, D. & Der, C. J. Inhibition of Ras for cancer treatment: The search continues. Future Med. Chem. 3, 1787-1808 (2011
24. Guo, B. & Sharrocks, A. D. Extracellular signal-regulated kinase mitogenactivated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3. Mol. Cell Biol. 29, 3204-3218 (2009
25. Iwasaki, M. et al. E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. Exp. Cell Res. 299, 525-532 (2004
26. Chien, Y. et al. Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125-2136 (2011
27. Rodier, F. et al. Persistent DNA damage signalling triggers senescenceassociated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973-979 (2009
28. Garg, A. D. et al. ER stress-induced inflammation: Does it aid or impede disease progression Trends. Mol. Med. 18, 589-598 (2012
29. Ullman, E., Pan, J. A. & Zong, W. X. Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury. Mol. Cell. Biol. 31, 2902-2919 (2011
30. Denoyelle, C. et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat. Cell Biol. 8, 1053-1063 (2006
31. Maitra, A. & Hruban, R. H. Pancreatic cancer. Annu. Rev. Pathol. 3, 157-188 (2008
32. Pei, H. et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259-266 (2009
33. Badea, L., Herlea, V., Dima, S. O., Dumitrascu, T. & Popescu, I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55, 2016-2027 (2008
34. Iacobuzio-Donahue, C. A. et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162, 1151-1162 (2003
35. Segara, D. et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin. Cancer Res. 11, 3587-3596 (2005
36. Grutzmann, R. et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6, 611-622 (2004
37. Logsdon, C. D. et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 63, 2649-2657 (2003
38. Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248 (2001
39. Luke, C. J. et al. An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury. Cell 130, 1108-1119 (2007
40. Wang, S. & Kaufman, R. J. The impact of the unfolded protein response on human disease. J. Cell Biol. 197, 857-867 (2012
41. Luo, B. & Lee, A. S. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32, 805-818 (2013
42. De Raedt, T. et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 20, 400-413 (2011
43. Terzic, J., Grivennikov, S., Karin, E. & Karin, M. Inflammation and colon cancer. Gastroenterology 138, 2101-2114 e2105 (2010
44. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002
45. Meylan, E. et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462, 104-107 (2009
46. Katagiri, C., Nakanishi, J., Kadoya, K. & Hibino, T. Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase. J. Cell Biol. 172, 983-990 (2006
47. Vidalino, L. et al. SERPINB3, apoptosis and autoimmunity. Autoimmun. Rev. 9, 108-112 (2009
48. Murakami, A. et al. Squamous cell carcinoma antigen suppresses radiationinduced cell death. Br. J. Cancer 84, 851-858 (2001
49. Suminami, Y. et al. Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. Cancer Res. 61, 1776-1780 (2001
50. Baron, J. A. et al. A randomized trial of aspirin to prevent colorectal adenomas. New Engl. J. Med. 348, 891-899 (2003
51. Sandler, R. S. et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. New Engl. J. Med. 348, 883-890 (2003
52. Khosravi-Far, R. et al. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell Biol. 16, 3923-3933 (1996
53. Slack, J. K., Catling, A. D., Eblen, S. T., Weber, M. J. & Parsons, J. T. c-Raf-mediated inhibition of epidermal growth factor-stimulated cell migration. J. Biol. Chem. 274, 27177-27184 (1999).